RBM12B is an RNA-binding protein located on chromosome 8 that functions in RNA splicing and ribonucleoprotein complex assembly 1. As an RNA binding motif protein, RBM12B participates in regulation of RNA splicing through its protein-RNA interaction capabilities, with expression patterns that vary across normal and diseased tissues. RBM12B has emerged as a significant biomarker across multiple disease contexts. In sarcoidosis, RBM12B was identified as part of a validated 20-gene peripheral blood molecular signature distinguishing sarcoidosis patients from healthy controls with 86% accuracy and predicting risk for complicated sarcoidosis progression 2. In head and neck squamous cell carcinoma (HNSCC), RBM12B was included in a six-gene splicing factor signature predicting patient prognosis, though its specific mechanistic role remains less characterized compared to other signature members 1. RBM12B also functions as a hub gene in hepatocellular carcinoma pathways, associated with DNA replication and cell cycle regulation 3. In colon cancer, RBM12B was identified as a significant prognostic biomarker within a competing endogenous RNA network, with expression levels correlating with patient overall survival 4. Furthermore, RBM12B lies within commonly amplified chr8 regions (8q12.1 and 8q22.1) in human breast cancer, where it is associated with worse overall survival, suggesting its role as a potential breast cancer risk modifier 5.